Karla C.S. Queiroz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Tuberous sclerosis complex (TSC) is caused by inactivating mutations in either TSC1 or TSC2 and is characterized by uncontrolled mTORC1 activation. Drugs that reduce mTOR activity are only partially successful in the treatment of TSC, suggesting that mTOR-independent pathways play a role in disease development. Here, kinome profiles of wild-type and(More)
  • 1